FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134061805> ?p ?o ?g. }

• W3134061805 endingPage "309" @default.
• W3134061805 startingPage "301" @default.
• W3134061805 abstract "Opioid agonist treatment (OAT) reduces many of the harms associated with opioid dependence. We use mathematical modelling to comprehensively evaluate the overall health benefits of OAT in people who inject drugs in Perry County (KY, USA), Kyiv (Ukraine), and Tehran (Iran).We developed a dynamic model of HIV and hepatitis C virus (HCV) transmission, incarceration, and mortality through overdose, injury, suicide, disease-related and other causes. The model was calibrated to site-specific data using Bayesian methods. We evaluated preventable drug-related deaths (deaths due to HIV, HCV, overdose, suicide, or injury) averted over 2020-40 for four scenarios, added incrementally, compared with a scenario without OAT: existing OAT coverage (setting-dependent; community 4-11%; prison 0-40%); scaling up community OAT to 40% coverage; increasing average OAT duration from 4-14 months to 2 years; and scaling up prison-based OAT.Drug-related harms contributed differentially to mortality across settings: overdose contributed 27-47% (range of median projections) of preventable drug-related deaths over 2020-40, suicide 6-17%, injury 3-17%, HIV 0-59%, and HCV 2-18%. Existing OAT coverage in Tehran (31%) could have a substantial effect, averting 13% of preventable drug-related deaths, but will have negligible effect (averting <2% of preventable drug-related deaths) in Kyiv and Perry County due to low OAT coverage (<4%). Scaling up community OAT to 40% could avert 12-24% of preventable drug-related deaths, including 13-22% of overdose deaths, with greater effect in settings with significant HIV mortality (Tehran and Kyiv). Improving OAT retention and providing prison-based OAT would have a significant additional effect, averting 27-51% of preventable drug-related deaths.OAT can substantially reduce drug-related harms, particularly in settings with HIV epidemics in people who inject drugs. Maximising these effects requires research and investment into achieving higher coverage and provision and longer retention of OAT in prisons and the community.UK National Institute for Health Research, US National Institute on Drug Abuse." @default.
• W3134061805 created "2021-03-15" @default.
• W3134061805 creator A5003380925 @default.
• W3134061805 creator A5007290128 @default.
• W3134061805 creator A5009408993 @default.
• W3134061805 creator A5018786986 @default.
• W3134061805 creator A5036570109 @default.
• W3134061805 creator A5045529959 @default.
• W3134061805 creator A5052916430 @default.
• W3134061805 creator A5056245742 @default.
• W3134061805 creator A5058849441 @default.
• W3134061805 creator A5071334665 @default.
• W3134061805 creator A5079160279 @default.
• W3134061805 creator A5079856927 @default.
• W3134061805 creator A5082117571 @default.
• W3134061805 date "2021-04-01" @default.
• W3134061805 modified "2023-10-01" @default.
• W3134061805 title "Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis" @default.
• W3134061805 cites W1500956687 @default.
• W3134061805 cites W1995021702 @default.
• W3134061805 cites W2009247197 @default.
• W3134061805 cites W2051366813 @default.
• W3134061805 cites W2063836800 @default.
• W3134061805 cites W2118672557 @default.
• W3134061805 cites W2132090500 @default.
• W3134061805 cites W2152187555 @default.
• W3134061805 cites W2155524218 @default.
• W3134061805 cites W2159160564 @default.
• W3134061805 cites W2165347494 @default.
• W3134061805 cites W2469883028 @default.
• W3134061805 cites W2470822429 @default.
• W3134061805 cites W2594572380 @default.
• W3134061805 cites W2608446001 @default.
• W3134061805 cites W2754268575 @default.
• W3134061805 cites W2765091655 @default.
• W3134061805 cites W2765348434 @default.
• W3134061805 cites W2799522112 @default.
• W3134061805 cites W2884203623 @default.
• W3134061805 cites W2884490732 @default.
• W3134061805 cites W2889112156 @default.
• W3134061805 cites W2903486531 @default.
• W3134061805 cites W2947994209 @default.
• W3134061805 cites W2982015067 @default.
• W3134061805 cites W3009583371 @default.
• W3134061805 doi "https://doi.org/10.1016/s2215-0366(20)30538-1" @default.
• W3134061805 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8255389" @default.
• W3134061805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33640039" @default.
• W3134061805 hasPublicationYear "2021" @default.
• W3134061805 type Work @default.
• W3134061805 sameAs 3134061805 @default.
• W3134061805 citedByCount "16" @default.
• W3134061805 countsByYear W31340618052021 @default.
• W3134061805 countsByYear W31340618052022 @default.
• W3134061805 countsByYear W31340618052023 @default.
• W3134061805 crossrefType "journal-article" @default.
• W3134061805 hasAuthorship W3134061805A5003380925 @default.
• W3134061805 hasAuthorship W3134061805A5007290128 @default.
• W3134061805 hasAuthorship W3134061805A5009408993 @default.
• W3134061805 hasAuthorship W3134061805A5018786986 @default.
• W3134061805 hasAuthorship W3134061805A5036570109 @default.
• W3134061805 hasAuthorship W3134061805A5045529959 @default.
• W3134061805 hasAuthorship W3134061805A5052916430 @default.
• W3134061805 hasAuthorship W3134061805A5056245742 @default.
• W3134061805 hasAuthorship W3134061805A5058849441 @default.
• W3134061805 hasAuthorship W3134061805A5071334665 @default.
• W3134061805 hasAuthorship W3134061805A5079160279 @default.
• W3134061805 hasAuthorship W3134061805A5079856927 @default.
• W3134061805 hasAuthorship W3134061805A5082117571 @default.
• W3134061805 hasBestOaLocation W31340618052 @default.
• W3134061805 hasConcept C126322002 @default.
• W3134061805 hasConcept C170493617 @default.
• W3134061805 hasConcept C194828623 @default.
• W3134061805 hasConcept C2776315796 @default.
• W3134061805 hasConcept C2778949969 @default.
• W3134061805 hasConcept C2781063702 @default.
• W3134061805 hasConcept C3013748606 @default.
• W3134061805 hasConcept C3017944768 @default.
• W3134061805 hasConcept C512399662 @default.
• W3134061805 hasConcept C529928208 @default.
• W3134061805 hasConcept C71924100 @default.
• W3134061805 hasConcept C99454951 @default.
• W3134061805 hasConceptScore W3134061805C126322002 @default.
• W3134061805 hasConceptScore W3134061805C170493617 @default.
• W3134061805 hasConceptScore W3134061805C194828623 @default.
• W3134061805 hasConceptScore W3134061805C2776315796 @default.
• W3134061805 hasConceptScore W3134061805C2778949969 @default.
• W3134061805 hasConceptScore W3134061805C2781063702 @default.
• W3134061805 hasConceptScore W3134061805C3013748606 @default.
• W3134061805 hasConceptScore W3134061805C3017944768 @default.
• W3134061805 hasConceptScore W3134061805C512399662 @default.
• W3134061805 hasConceptScore W3134061805C529928208 @default.
• W3134061805 hasConceptScore W3134061805C71924100 @default.
• W3134061805 hasConceptScore W3134061805C99454951 @default.
• W3134061805 hasFunder F4320319990 @default.
• W3134061805 hasFunder F4320337347 @default.
• W3134061805 hasIssue "4" @default.
• W3134061805 hasLocation W31340618051 @default.
• W3134061805 hasLocation W31340618052 @default.

• next